KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Assets Average (2016 - 2025)

Historic Assets Average for Neogenomics (NEO) over the last 17 years, with Q3 2025 value amounting to $1.4 billion.

  • Neogenomics' Assets Average fell 1570.03% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year decrease of 1570.03%. This contributed to the annual value of $1.7 billion for FY2024, which is 298.12% down from last year.
  • According to the latest figures from Q3 2025, Neogenomics' Assets Average is $1.4 billion, which was down 1570.03% from $1.5 billion recorded in Q2 2025.
  • In the past 5 years, Neogenomics' Assets Average ranged from a high of $1.9 billion in Q3 2021 and a low of $762.0 million during Q1 2021
  • In the last 5 years, Neogenomics' Assets Average had a median value of $1.7 billion in 2023 and averaged $1.6 billion.
  • Its Assets Average has fluctuated over the past 5 years, first surged by 28180.57% in 2021, then crashed by 1570.03% in 2025.
  • Quarter analysis of 5 years shows Neogenomics' Assets Average stood at $1.9 billion in 2021, then decreased by 7.43% to $1.7 billion in 2022, then dropped by 3.89% to $1.7 billion in 2023, then decreased by 2.39% to $1.6 billion in 2024, then decreased by 15.57% to $1.4 billion in 2025.
  • Its last three reported values are $1.4 billion in Q3 2025, $1.5 billion for Q2 2025, and $1.6 billion during Q1 2025.